Systemic Biomarkers in 2-Phase Antibiotic Periodontal Treatment: A Randomized Clinical Trial
Contributeurs/tricesGiannopoulou, Catherine; Cionca, Norbert; Almaghlouth, Adnan Ali; Cancela, José Antonio; Courvoisier, Delphine; Mombelli, Andrea
Publié dansJournal of dental research, vol. 95, no. 3, p. 349-355
Date de publication2016
Résumé
Mots-clés
- Acute phase proteins
- Antimicrobials
- Clinical research
- Cytokines
- Periodontal therapy
- Serum
- Acute-Phase Proteins/analysis
- Adult
- Aged
- Aggressive Periodontitis/blood/drug therapy/surgery
- Amoxicillin/therapeutic use
- Anti-Bacterial Agents/therapeutic use
- Biomarkers/blood
- Calcitonin/blood
- Chronic Periodontitis/blood/drug therapy/surgery
- Combined Modality Therapy
- Cytokines/blood
- Double-Blind Method
- Female
- Ferritins/blood
- Follow-Up Studies
- Haptoglobins/analysis
- Humans
- Inflammation Mediators/blood
- Interleukin 1 Receptor Antagonist Protein/blood
- Interleukin-10/blood
- Male
- Metronidazole/therapeutic use
- Middle Aged
- Periodontal Debridement/methods
- Placebos
- Protein Precursors/blood
- Serum Amyloid P-Component/analysis
Financement
- Swiss National Science Foundation - Antimicrobial therapy as adjunct to periodontal treatment: effect of different timing on clinical, microbiological and systemic response
Citation (format ISO)
GIANNOPOULOU, Catherine et al. Systemic Biomarkers in 2-Phase Antibiotic Periodontal Treatment: A Randomized Clinical Trial. In: Journal of dental research, 2016, vol. 95, n° 3, p. 349–355. doi: 10.1177/0022034515618949
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:89753
- DOI : 10.1177/0022034515618949
- PMID : 26604272
ISSN du journal0022-0345